Debasish Tripathy

Debasish Tripathy

UNVERIFIED PROFILE

Are you Debasish Tripathy?   Register this Author

Register author
Debasish Tripathy

Debasish Tripathy

Publications by authors named "Debasish Tripathy"

Are you Debasish Tripathy?   Register this Author

29Publications

1004Reads

9Profile Views

Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.

Breast Cancer Res Treat 2019 Aug 15;176(3):687-696. Epub 2019 Feb 15.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05165-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588417PMC
August 2019

Correction to: Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.

Breast Cancer Res Treat 2019 08;176(3):697

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05292-yDOI Listing
August 2019

What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer.

Support Care Cancer 2019 Apr 2. Epub 2019 Apr 2.

Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-019-04770-9
Publisher Site
http://dx.doi.org/10.1007/s00520-019-04770-9DOI Listing
April 2019

Neurocognitive deficits in older patients with cancer.

J Geriatr Oncol 2018 09 9;9(5):482-487. Epub 2018 Mar 9.

Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2018.02.010DOI Listing
September 2018

Overall survival in older patients with cancer.

BMJ Support Palliat Care 2018 Sep 22. Epub 2018 Sep 22.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2018-001516DOI Listing
September 2018

Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers.

Ann Diagn Pathol 2018 Aug 3;35:69-76. Epub 2018 May 3.

Department of Pathology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2018.04.004DOI Listing
August 2018

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

Support Care Cancer 2018 May 2;26(5):1561-1568. Epub 2017 Dec 2.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3962-7DOI Listing
May 2018

Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.

JAMA Oncol 2017 Sep;3(9):1266-1273

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.4975DOI Listing
September 2017

Modified Bi-Rads Scoring of Breast Imaging Findings Improves Clinical Judgment.

Breast J 2015 Nov-Dec;21(6):642-50. Epub 2015 Sep 28.

Division of Medical Oncology, Kenneth Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12492DOI Listing
August 2016

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

J Clin Oncol 2016 08 2;34(22):2602-9. Epub 2016 May 2.

Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.1595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012690PMC
August 2016

Adaptive Randomization of Neratinib in Early Breast Cancer.

N Engl J Med 2016 Jul;375(1):11-22

From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota; M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; Gemini Group, Ann Arbor, MI (J.P.); University of Pennsylvania, Philadelphia (A.D.); Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); Swedish Medical Center, Seattle (H.G.K.); University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago; Inova Fairfax Hospital, Falls Church, VA (K.K.E.); University of Denver, Denver (A.D.E.); Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona; University of Kansas, Lawrence (Q.J.K.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259558PMC
July 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

N Engl J Med 2016 Jul;375(1):23-34

From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259561PMC
July 2016

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative.

J Cancer 2015 23;6(7):610-5. Epub 2015 May 23.

1. Clinical Cancer Genetics, the University of Texas MD Anderson Cancer Center, Houston, TX ; 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.11710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466409PMC
June 2015

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

J Surg Oncol 2015 Jan 5;111(1):81-90. Epub 2014 Aug 5.

University of Southern California Department of Surgery, Division of Breast and Soft Tissue Surgery, Norris Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23732DOI Listing
January 2015

Expression profiling of circulating tumor cells in metastatic breast cancer.

Breast Cancer Res Treat 2015 Jan 29;149(1):121-31. Epub 2014 Nov 29.

Division of Breast and Soft Tissue Surgery, Department of Surgery, Norris Comprehensive Cancer Center (NCCC), University of Southern California (USC), 1510 San Pablo Street Suite 412, Los Angeles, CA, 90033-0800, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3215-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698170PMC
January 2015

Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer.

Clin Breast Cancer 2005 Jun;6(2):150-7

Department of Medicine, Case Western Reserve University, Cleveland, OH 44106-5055, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2005.n.017DOI Listing
June 2005

Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro.

Anticancer Res 2002 Nov-Dec;22(6C):3843-52

Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
March 2003